Recruiting

Lymphatic Surgery

Sponsor:

University Hospital, Basel, Switzerland

Code:

NCT05890677

Conditions

Lymphedema, Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Intervention

Conservative Complex Physical Decongestion Therapy

Study Details

Brief summary:

The aim of this study is to test whether lymphatic surgery provides better QoL (assessed with the Lymph-ICF-UL, (Lymphedema Functioning Disability and health questionnaire for upper limb lymphedema)) 15 months after randomization (and therefore about one year after surgery) compared to conservative treatment only for patients with chronic lymphedema (LE)

Conditions

Lymphedema, Breast Cancer

Study ID

NCT05890677

Start date

Jul 14, 2023

Status verified date

Jun, 2026

Completion date

Jun, 2036

Anticipated

Primary completion date

Sep, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Written informed consent.
  • Patients ≥ 18 years of age.
  • Former diagnosis of breast cancer.
  • Clinical diagnosis of chronic Breast Cancer-Related Lymphedema (BCRL) (persisting for more than 3 months) classified as ≥ Stage 1, according to ISL.
  • Minimum of 3 months Conservative Complex Physical Decongestion Therapy.
  • Ability to complete the QoL questionnaires.
  • Willingness to undergo surgery.

Exclusion Criteria:

  • No indication for lymphatic surgery according to clinical judgment of the treating surgeon (individual reasons will be specifically documented).
  • Primary congenital Lymphedema or non-BCRL.
  • Previous surgical BCRL treatment on the side intended for intervention.

Study Design

Enrollment

280 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Group A : Surgical Group

According to the pragmatic study design, neither the diagnostic workup nor the surgery will be standardized in order to offer surgeons considerable leeway on how to perform lymphatic surgery, which resembles the flexibility in usual care. The key aspects of the preoperative workup and the surgery including the number of LVAs (Lymphovenous Anastomosis), harvesting of lymph nodes ("donor site"), time of surgery, and practical details will be registered.

active comparator: Group B: Conservative Complex Physical Decongestion Therapy (control group)

CDT (Conservative Complex Physical Decongestion Therapy) will be performed as in usual care, following the pragmatic study design. The key aspects like frequency of lymphatic drainage, time when lymphatic drainage is performed and time and class of compressive garments are used will be documented. CDT incorporates two stages of treatment. The first treatment phase (intensive phase) entails skincare, MLD (manual lymphatic drainage), exercises aimed at improvement of mobility/range of motion in the shoulder, elbow or wrist joints, and compression therapy through bandaging. Most patients undergo this phase shortly after the diagnosis of LE. CDT in the second phase (maintenance phase) aims to maintain the achieved limb volume/ circumference reduction through compression with therapeutic elastic compression garment for the arm. Skincare, mobility exercises and MLD is continued in this phase if needed

Interventions

Surgical Intervention

LVA (Lymphovenous Anastomosis) and VLNT (Vascularised Lymph Node Transfer) are two advanced microsurgical techniques that are increasingly implemented in clinical practice in specialized centers and that are already carried out after health insurance application according to local standard of care. They have been studied in their respective mode of action as well as in their effectiveness in treating chronic BCRL (Breast Cancer-Related Lymphedema) in a multitude of mostly observational and single center studies with highly encouraging results. Patients in the interventional arm A will receive surgery with one of the two approaches or a combination of both, in a one or two-stage method, at the discretion of the treating surgeon. Depending on local standards one or both of the above might be combined with liposuction to the affected arm in a one or two-stage approach as well.

Conservative Complex Physical Decongestion Therapy

Patients randomized to the control arm will receive CDT (Conservative Complex Physical Decongestion Therapy), which currently is considered as the best available standard of care. For this, patients will be referred to one of the dedicated LE (physical/skin) therapy clinics, if not already treated by one, according to their place of residence for continuation of standard conservative therapy. Recommendations to the procedures and treatment frequency of the conservative therapy will be made, but CDT will be done at the discretion of the treating physiotherapist.

Primary outcome measure

  • Change in Quality of Life Questionnaire (Lymph-ICF-UL) [ Time Frame: two time assessment at baseline and 15 month after randomization ]

Central Contacts and Locations

Central contacts

Elisabeth Kappos, Prof. Dr.

+41 61 328 62 54elisabeth.kappos@usb.ch

Locations

Harvard Medical School

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

Andrea Pusic, Prof. Dr. med.

+16 17 732 53 61apusic@bwh.harvard.edu

Washington University School of Medicine in St. Louis

Recruiting

St Louis, Missouri, United States, 63110

Contacts

Justin M. Sacks, Prof. Dr.

+1 314-454-4894jmsacks@wustl.edu

McGill University, Royal Victoria Hospital

Recruiting

Montreal, Canada, QC H4A 3J1

Contacts

University of British Columbia, Gordon and Leslie Diamond Health Care Centre

Recruiting

Vancouver, Canada, BC V5Z 1M9

Contacts

Kathryn V. Isaac, Asst. Prof. Dr.

+1 604-336-9488kathryn.isaac@ubc.ca

More Information

Sponsor

University Hospital, Basel, Switzerland

Last update posted

Jun 4, 2026

Last verified

Jun, 2026

Keywords

  • lymphatic surgery
  • breast cancer related lymphedema
  • sentinel lymph node biopsy
  • axillary lymph node dissection
  • manual lymphatic drainage
  • conservative complex physical decongestion therapy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University Hospital, Basel, Switzerland on 2026-06-04.